Evidence map›Paper›PMID 34521429›Full record

ArticleJournal of experimental & clinical cancer research : CR2021

The non-canonical mechanism of ER stress-mediated progression of prostate cancer.

Artem N Pachikov, Ryan R Gough, Caroline E Christy, Mary E Morris, Carol A Casey, Chad A LaGrange, Ganapati Bhat, Anatoly V Kubyshkin, Iryna I Fomochkina, Evgeniya Y Zyablitskaya and 11 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Combined Inhibition ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

Artem N PachikovDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Ryan R GoughDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Caroline E ChristyDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mary E MorrisDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Carol A CaseyOmaha Western Iowa Health Care System, VA Service, Department of Research Service, Omaha, NE, 68105, USA.
Chad A LaGrangeDivision of Urologic Surgery, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Ganapati BhatSchool of Basic and Applied Sciences, Dayananda Sagar University, Bangalore, Karnataka, 560078, India.
Anatoly V KubyshkinDepartment of Pathological Physiology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Iryna I FomochkinaDepartment of Pathological Physiology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Evgeniya Y ZyablitskayaLaboratory of Molecular Biology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Tatiana P MakalishLaboratory of Molecular Biology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Elena P GolubinskayaLaboratory of Molecular Biology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Kateryna A DavydenkoLaboratory of Molecular Biology, Medical Academy named after S. I. Georgievsky, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Sergey N EremenkoSaint Luc's Clinique, V. I. Vernadsky Crimean Federal University, Simferopol, Russia, 295051.
Jean-Jack M RiethovenCenter for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Amith S MaroliThe Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Thomas S PayneDepartment of Statistics, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Robert PowersThe Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
Alexander Y LushnikovNanoimaging Core Facility, University of Nebraska Medical Center, Omaha, NE, 68105, USA.
Amanda J MackeDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Armen PetrosyanDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA. apetrosyan@unmc.edu.
Research Institute of Agriculture of Crimea · RUUniversity of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · USVA Nebraska Western Iowa Health Care System · USDayananda Sagar UniversityNebraska Medical Center · USSusan Thompson Buffett Foundation · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI James Eudy · 1985 to 2026
$55.0M
Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GUO, JIANTAO · 2016 to 2025
$20.8M
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver DiseaseR01AA020735 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CASEY, CAROL A., MC NIVEN, MARK A. · 2011 to 2025
$8.1M
The role for alcohol-induced Golgi disorganization in the progression of prostate cancerR01AA027242 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PETROSYAN, ARMEN · 2019 to 2023
$1.7M
BLRD VA I01 BX004171NIAAA NIH HHS R01 AA020735NIAAA NIH HHS R01AA020735NIAAA NIH HHS R01 AA027242NIGMS NIH HHS P20 GM113126Office of Academic Affiliations, Department of Veterans Affairs I01BX004171
6 · The paper itself

Abstract

backgroundThe development of persistent endoplasmic reticulum (ER) stress is one of the cornerstones of prostate carcinogenesis; however, the mechanism is missing. Also, alcohol is a physiological ER stress inducer, and the link between alcoholism and progression of prostate cancer (PCa) is well documented but not well characterized. According to the canonical model, the mediator of ER stress, ATF6, is cleaved sequentially in the Golgi by S1P and S2P proteases; thereafter, the genes responsible for unfolded protein response (UPR) undergo transactivation.

methodsCell lines used were non-malignant prostate epithelial RWPE-1 cells, androgen-responsive LNCaP, and 22RV1 cells, as well as androgen-refractory PC-3 cells. We also utilized PCa tissue sections from patients with different Gleason scores and alcohol consumption backgrounds. Several sophisticated approaches were employed, including Structured illumination superresolution microscopy, Proximity ligation assay, Atomic force microscopy, and Nuclear magnetic resonance spectroscopy.

resultsHerein, we identified the trans-Golgi matrix dimeric protein GCC185 as a Golgi retention partner for both S1P and S2P, and in cells lacking GCC185, these enzymes lose intra-Golgi situation. Progression of prostate cancer (PCa) is associated with overproduction of S1P and S2P but monomerization of GCC185 and its downregulation. Utilizing different ER stress models, including ethanol administration, we found that PCa cells employ an elegant mechanism that auto-activates ER stress by fragmentation of Golgi, translocation of S1P and S2P from Golgi to ER, followed by intra-ER cleavage of ATF6, accelerated UPR, and cell proliferation. The segregation of S1P and S2P from Golgi and activation of ATF6 are positively correlated with androgen receptor signaling, different disease stages, and alcohol consumption. Finally, depletion of ATF6 significantly retarded the growth of xenograft prostate tumors and blocks production of pro-metastatic metabolites.

conclusionsWe found that progression of PCa associates with translocation of S1P and S2P proteases to the ER and subsequent ATF6 cleavage. This obviates the need for ATF6 transport to the Golgi and enhances UPR and cell proliferation. Thus, we provide the novel mechanistic model of ATF6 activation and ER stress implication in the progression of PCa, suggesting ATF6 is a novel promising target for prostate cancer therapy.

Indexed as

Endoplasmic Reticulum StressAnimalsCell Line, TumorDisease Models, AnimalDisease ProgressionEndoplasmic ReticulumGolgi ApparatusHeterograftsHumansMaleMetalloendopeptidasesMiceMitochondrial Proton-Translocating ATPasesProprotein ConvertasesProstatic NeoplasmsProtein BindingMBTPS2 protein, humanmembrane-bound transcription factor peptidase, site 1MetalloendopeptidasesMitochondrial Proton-Translocating ATPasesMT-ATP6 protein, humanProprotein ConvertasesSerine EndopeptidasesAlcohol abuseER stressGolgi fragmentationProstate cancer

Identifiers

PMID34521429
PMCPMC8439065
OpenAlexW3169236842

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.